-+ 0.00%
-+ 0.00%
-+ 0.00%

ARVINAS SHARES NOVEL OCULOMOTOR AND BIOMARKER DATA FROM PHASE 1 CLINICAL TRIAL OF ARV-102 IN PATIENTS WITH PARKINSON’S DISEASE

Reuters·10/07/2026 11:03:07

Please log in to view news